We are live on
!
Find out more
MP
Mangrove Partners Portfolio holdings
AUM
$1.24B
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
-0.28%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$415M
AUM Growth
+$53.2M
(+15%)
Cap. Flow
+$6.09M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
51.96%
Holding
55
New
14
Increased
13
Reduced
3
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$19.4M |
| 2 |
AT
Atlantic Power Corporation
AT
|
+$13.6M |
| 3 |
ECHO
EchoStar
ECHO
|
+$11.8M |
| 4 |
NFX
Newfield Exploration
NFX
|
+$11.7M |
| 5 |
TLM
TALISMAN ENERGY INC
TLM
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$19.3M |
| 2 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$18.6M |
| 3 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$18.6M |
| 4 |
FUR
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
|
+$13.8M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 22.12% |
| 2 | Financials | 17.23% |
| 3 | Energy | 8% |
| 4 | Communication Services | 4.95% |
| 5 | Healthcare | 4.89% |
Similar funds
GX
HCA
CA
WTA
NHAS
FLII
CCA
IC
Mangrove Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Mangrove Partners held 55 positions worth $415M, up 15% from $362M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Mangrove Partners's Q1 2015 filing shows 14 new, 13 increased, 3 reduced and 13 closed positions. Its largest new stake was Eiger BioPharmaceuticals, Inc.: 2,222 shares worth $18.9M. The largest sale was Allergan Inc, an estimated $19.3M.
By sector, the portfolio is most concentrated in Real Estate at 22% of assets, down from 27% a quarter earlier, followed by Financials and Energy.
- Mangrove Partners's largest Q1 2015 buy was Eiger BioPharmaceuticals, Inc.: 2,222 shares worth $18.9M.
- Mangrove Partners added most to Atlantic Power Corporation in Q1 2015, an estimated $13.6M increase.
- Mangrove Partners's biggest Q1 2015 reduction was Ready Capital, cutting an estimated $1.43M.
- Mangrove Partners fully exited Allergan Inc in Q1 2015, selling an estimated $19.3M.
- Mangrove Partners's ten largest holdings make up 52% of its $415M portfolio in Q1 2015.
- Mangrove Partners opened 14 new positions and closed 13 in Q1 2015.
- Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $415M.
Based on Mangrove Partners's 13F filing for Q1 2015, filed 15 May 2015.